Illumina forecasts 2025 revenue largely below estimates
1. Illumina's 2025 revenue forecast falls short of Wall Street estimates, indicating low demand. 2. Shares declined nearly 4% after the revenue forecast announcement.
1. Illumina's 2025 revenue forecast falls short of Wall Street estimates, indicating low demand. 2. Shares declined nearly 4% after the revenue forecast announcement.
The revenue forecast below expectations suggests weakened market confidence, similar to past experiences where subdued forecasts led to stock declines.
Forecasts related to revenue significantly impact investor sentiment and stock performance, especially in biotech.
Immediate market reaction indicates short-term price volatility may occur, resembling past forecast impacts.